(Q42945701)

English

Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational study

scientific article published on October 1, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1

object named as

Jaco Voorham

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20687048

17 June 2024

author name string

Klaas van der Meer

3

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Dick de Zeeuw

4

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Klaas Hoogenberg

6

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Petra Denig

7

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

GIANTT-Group

8

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Floor M. Haaijer-Ruskamp

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20687048

17 June 2024

Bruce H. R. Wolffenbuttel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20687048

17 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20687048

17 June 2024

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpds.2023

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.2023

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Pharmacoepidemiology and Drug Safety

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1078-1086

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2023

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2023

21 January 2018

Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care

2

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Logistic support service improves processes and outcomes of diabetes care in general practice.

3

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Resource consumption and costs in Dutch patients with Type 2 diabetes mellitus. Results from 29 general practices

4

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets

5

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Task delegation and computerized decision support reduce coronary heart disease risk factors in type 2 diabetes patients in primary care

6

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Combined task delegation, computerized decision support, and feedback improve cardiovascular risk for type 2 diabetic patients: a cluster randomized trial in primary care

7

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Overall quality of diabetes care in a defined geographic region: different sides of the same story

8

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Cross-sectional versus sequential quality indicators of risk factor management in patients with type 2 diabetes

10

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Treatment intensification and risk factor control: toward more clinically relevant quality measures

11

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Computerized extraction of information on the quality of diabetes care from free text in electronic patient records of general practitioners

13

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetes.

14

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study

19

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes

21

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change

24

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Clinical inertia in the management of Type 2 diabetes metabolic risk factors

25

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Tackling therapeutic inertia: role of treatment data in quality indicators

26

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Overall quality of diabetes care in a defined geographic region: different sides of the same story

28

1 reference

10.1002/PDS.2023

https://api.crossref.org/works/10.1002/PDS.2023

17 June 2024

Identifiers

10.1002/PDS.2023

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42945701&oldid=2181862992"